Cantor Fitzgerald lowered their FY2025 earnings per share (EPS) estimates for CVRx in a research report issued on Wednesday, ...
Symbotic (NASDAQ:SYM – Get Free Report)‘s stock had its “overweight” rating reiterated by Cantor Fitzgerald in a report released on Thursday,Benzinga reports. They presently have a $60.00 price target ...
We recently published a list of 9 Trending AI News Updates on Wall Street’s Radar. In this article, we are going to take a ...
Cantor Fitzgerald reaffirmed its Overweight rating on Neurocrine Biosciences stock (NASDAQ:NBIX) with a consistent price target of $170.00. Currently trading at $150.51, the stock has shown strong ...
As previously reported last night, Cantor Fitzgerald analyst Colin Canfield initiated coverage of five Government Technology & Space, or ...
Will the Senate GOP confirm controversial picks like Tulsi Gabbard and RFK Jr.? Here’s the hearings schedule and list of ...
Cantor Fitzgerald analyst Colin Canfield maintained a Hold rating on ViaSat (VSAT – Research Report) yesterday and set a price target of ...
It’s not that the Trump administration is anti-Goldman Sachs, sources say, but rather there just isn’t as much talent to take ...